Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Bortezomib 1.6 / Rituximab 375, Waldenström's disease, cycle 1+4

Protocol-ID: 1235 V1.0 (Mini), BORT1.6/RITU375, Waldenström, C1+4

Indication(s)

  • NHL, B-Cell Type, Lymphoplasmocytic / Waldenström's disease; ICD-10 C88.0-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 31.10.2019